HCPCS Code Descriptor:
Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
Phesgo is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9316 is aligned to the drug Phesgo.
Access Pricing and More By Registering
HCPCS Added Date:
HCPCS Effective Date:
HCPCS Short Description:
Pertuzu, trastuzu, 10 mg
Billing and Coding Guide: